Journal Mobile Options
Table of Contents
Vol. 57, No. 2, 2007
Issue release date: February 2007
Section title: Original Paper
Eur Neurol 2007;57:65–69
(DOI:10.1159/000098053)

The Effects of Carbamazepine, Valproic Acid and Phenobarbital on the Oxidative and Antioxidative Balance in Epileptic Children

Aycicek A. · Iscan A.
aSanliurfa Children‘s Hospital, bHarran University, Medical Faculty, Research Hospital, Department of Paediatric Neurology, Sanliurfa, Turkey

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 11/10/2005
Accepted: 8/10/2006
Published online: 12/15/2006

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2

ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)

For additional information: http://www.karger.com/ENE

Abstract

Background: Oxidative stress has been related in a wide variety of ways with nervous tissue. We studied the effect of antiepileptic monotherapy on serum level of total antioxidant capacity, lipid hydroperoxide, total peroxide, oxidative stress index, and individual serum antioxidants such as albumin, bilirubin and uric acid. Patients and Methods: We studied 122 subjects including healthy controls, untreated epileptic patients and epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Serum total antioxidant capacity was measured as an index of antioxidants, and total peroxide was measured as index of oxidative stress. The serum concentrations of uric acid, albumin, bilirubin and lipid hydroperoxide were monitored simultaneously. Results: We found that serum total antioxidant capacity levels were significantly decreased in the untreated group compared with the controls. Serum total peroxide levels were markedly increased in the untreated and carbamazepine-treated groups compared to in the controls; and lipid hydroperoxide and oxidative stress index levels were significantly higher in the phenobarbital-treated group than in the controls. Uric acid concentrations were significantly lower in the valproic-acid-treated group than in the untreated group, and total bilirubin concentrations were higher in the untreated group than in the controls. Conclusion: Epileptic children exposed to oxidative stress and conventional antiepileptic drugs change the oxidative/antioxidative balance. The serum oxidant and antioxidant status of epileptic children with valproic acid monotherapy are better regulated compared with children with carbamazepine and phenobarbital monotherapy.


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 11/10/2005
Accepted: 8/10/2006
Published online: 12/15/2006

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2

ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)

For additional information: http://www.karger.com/ENE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lindhout D, Hoppener RJ, Meinardi H: Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77–83.
  2. Liu CS, Wu HM, Kao SH, Wei YH: Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clin Neuropharmacol 1998;21:62–64.
  3. Hamed SA, Abdellah MM, El-Melegy N: Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 2004;96:465–473.
  4. Cengiz M, Yuksel A, Seven M: The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol Res 2000;41:423–425.
  5. Maertens P, Dyken P, Graf W, Pippenger C, Chronister R, Shah A: Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. Am J Med Genet 1995;57:225–228.
  6. Kurekci AE, Alpay F, Tanindi S, Gokcay E, Ozcan O, Akin R, Isimer A, Sayal A: Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 1995;36:600–604.
  7. Yuksel A, Cengiz M, Seven M, Ulutin T: Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies. J Child Neurol 2001;16:603–606.
  8. Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F: Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 2002;48:71–75.
  9. Sudha K, Rao AV, Rao A: Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001;303:19–24.
  10. Solowiej E, Sobaniec W: The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy. Neurol Neurochir Pol 2003;37:991–1003.

    External Resources

  11. Bolayir E, Celik K, Tas A, Topaktas S, Bakir S: The effects of oxcarbazepine on oxidative stress in epileptic patients. Methods Find Exp Clin Pharmacol 2004;26:345–348.
  12. Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
  13. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–285.
  14. Miyazawa T: Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 1989;7:209–217.
  15. Harma M, Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133:563–566.
  16. Arab K, Steghens JP: Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004;325:158–163.
  17. Aycicek A, Erel O, Kocyigit A: Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005;47:635–639.
  18. Aycicek A, Erel O, Kocyigit A: Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr 2005;164:775–778.
  19. Harma M, Harma M, Erel O: Oxidative stress in women with preeclampsia. Am J Obstet Gynecol 2005;192:656–657.
  20. Hamed SA, Abdellah MM: Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. J Pharmacol Sci 2004;96:349–359.
  21. Delanty N, Dichter MA: Oxidative injury in the nervous system. Acta Neurol Scand 1998;98:145–153.
  22. Yuksel A, Cengiz M, Seven M, Ulutin T: Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J Basic Clin Physiol Pharmacol 2000;11:73–81.
  23. Niketic V, Ristic S, Saicic ZS, Spasic M, Buzadzic B, Stojkovic M: Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy. Farmaco 1995;50:811–813.
  24. Gaskill CL, Cribb AE: Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs. Can Vet J 2000;41:555–558.
  25. Polidori MC, Mecocci P, Stahl W, Sies H: Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 2003;90:147–150.